tbuckley/cabot-search huggingface dataset:
MA06.11 Phase II Trial of Ensartinib for Advanced or Metastatic Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations
Authors: Y. Xia, M. Zhou, P. Tian, J. Zhao, Y. Jin, Z. Guo, D. Miao, Y. Lu, X. Le, Y. Zhang, W. Li
Journal: Journal of Thoracic Oncology (2024)
MA07.03 Systematic Engineering of TROP2 CAR T Cell Therapy to Overcome Resistance Pathways in EGFRmutant NSCLC
Authors: E.J. Brea, S. Baldacci, S. Chakravarti, A.P. Mottram, F. Facchinetti, A. Ramasubramanian, N. Savage, K. Ngo, H.V. Vo, B.A. Leeper, E.V. Ivanova, A. Saldanha, M.-A. Locquet, A. Salamah, C. Stornante, M. Campisi, N.R. Mahadevan, T.C. Thai, T.J. Haggerty, C. Nie, C. Deng, X. Wang, L.L. Liu, P.C. Gokhale, C.P. Paweletz, P.A. Jänne, D.A. Barbie, E.L. Smith
Journal: Journal of Thoracic Oncology (2024)
OA12.03 Osimertinib After Definitive CRT in Unresectable Stage III EGFR-mutated NSCLC: Safety Outcomes from the Phase 3 LAURA Study
Authors: T. Kato, X. Dong, T. Takahashi, N. Soparattanapaisarn, S.L. Geater, K.V. Nguyen, C.-L. Wang, E. Arriola, F. Moiseenko, L. Thompson, S. Harker, E. Grainger, E. Armenteros-Monterroso, A. Bolanos, S. Ramalingam, S. Lu
Journal: Journal of Thoracic Oncology (2024)
MA02.07 AI as Primary Reader in 4-IN-THE-LUNG-RUN Lung Cancer Screening Trial: Impact on Negative Misclassification and Referral Rate
Authors: A. Walstra, H.L. Lancaster, M.A. Heuvelmans, J.W. Gratama, M. Silva, M. Oudkerk
Journal: Journal of Thoracic Oncology (2024)
MA05.08 Follow-Up after First-Line Nivolumab Plus Ipilimumab in Patients with Pleural Mesothelioma: A Real-World Dutch Cohort Study (FLORA-Study)
Authors: L.H. Douma, M.M. Hofman, F. Zwierenga, A.I.G. Buma, J.H. Schouwink, J.A. Burgers, I. Smesseim, D.W. Dumoulin, J.G.J.V. Aerts, C.J. de Gooijer
Journal: Journal of Thoracic Oncology (2024)
MA05.05 External Validation of Proposed 9th Edition of TNM Classification for Thymic Epithelial Tumours: Institutional Series of 436 Cases
Authors: Y.Z. Zhang, A. Rice, K. Wassilew, C. Brambilla, J.L. Robertus, L. D'Sa, E. Lim, S. Begum, S. Buderi, S. Jordan, V. Anikin, J. Finch, N. Asadi, E. Beddow, J.L. Garner, J. Morjaria, R. Lee, F. McDonald, N. Tokaca, G. Antoniou, C.A. Ridge, S.P. Padley, P. Dalal, P.L. Shah, A. Devaraj, S. Popat, A.G. Nicholson
Journal: Journal of Thoracic Oncology (2024)
OA12.06 Intensified Chemo-Immuno-Radiotherapy with Durvalumab for Stage III NSCLCs: A Single Arm Phase II Study - PACIFIC-BRAZIL (LACOG 2218)
Authors: W.N. William, G.C. Junior, D.d.A. Matias, L.H.d.L. Araújo, T.V. Reis, V.B.G. Teixeira, G.D.J. Pinto, L.A.F. Ferrigno, S.N. Castro, C.M.T. Hidalgo Filho, D. Kischinhevsky, A.C.Z. Gelatti, R.G. de Jesus, T.F. Rebelatto, G. Werutsky
Journal: Journal of Thoracic Oncology (2024)
MA06.07 Patterns of Progression with Lorlatinib and Insights into Subsequent Anticancer Therapy Efficacy in Advanced ALK+ NSCLC
Authors: T. Mok, B.J. Solomon, M.R.G. Campelo, Y.-L. Wu, G. Streich, M. Zemanova, G. Zalcman, A. Bearz, G.-C. Chang, M. Setti, A. Polli, Y. Goto
Journal: Journal of Thoracic Oncology (2024)
MA02.08 Performance of A Blood-based Protein Biomarker Panel in the National Lung Screening Trial
Authors: E. Ostrin, E. Irajizad, S.M. Ghasemi, J.F. Fahrmann, J.V. Vykoukal, J.B. Dennison, S.M. Hanash
Journal: Journal of Thoracic Oncology (2024)
MA02.03 Circulating T Cell Receptor Repertoire Analysis Improves Cancer Early Detection
Authors: Y. Li, M. Nahas, D. Stephens, K. Froburg, E. Hintz, D. Champagne, A. Lochab, M. Brown, J. Braun, M.A. Fortuño, M-d-M. Ocón, A. Pasquier, I.M. Luque, C.W. Seder, J.A. Borgia, L.M. Seijo, L.M. Montuenga, R. Yelensky
Journal: Journal of Thoracic Oncology (2024)
MA05.11 Phase 3 Trial of Pleurodesis for Malignant Pleurisy: Sterile Graded Talc vs. OK-432 WJOG8415L (J-PLEURA)
Authors: H. Saka, C. Kitagawa, Y. Shiraishi, Y. Sato, M. Yamaguchi, S. Sugawara, M. Oki, K. Nishino, K. Hosoi, S. Suzuki, A. Kubo, E. Tabata, K. Yoshimura, M. Ando, K. Nakagawa, N. Yamamoto, I. Okamoto
Journal: Journal of Thoracic Oncology (2024)
MA03.04 A Deep Learning Model to Predict Occult Lymphatic Metastasis in Clinical Stage I Non-Small Cell Lung Cancer Based on Chest CT
Authors: Y. Fu, R. Hou, X. Fu, L. Qian, W. Feng, Q. Zhang, Z. Ding, W. Yu, X. Cai, J. Liu
Journal: Journal of Thoracic Oncology (2024)
MA06.13 Updated Safety Analysis of Encorafenib Plus Binimetinib in Patients with BRAF V600e-Mutant Metastatic NSCLC from PHAROS Study
Authors: E. Smit, M.-J. Ahn, I. Dagogo-Jack, E. Felip, F. Gelsomino, B. Johnson, M. Johnson, M.V. Negrao, M. Offin, S. Ramalingam, R. Sanborn, A. Tsao, K. Wilner, A. Alcasid, T. Usari, X. Zhang, G. Riely
Journal: Journal of Thoracic Oncology (2024)
MA02.12 UC Screen California: A Statewide Participatory Informatics Approach to Lung Cancer Screening
Authors: A.L. Cummings, H.I. Tupper, Y. Lin, H.B. Keshava, G. Sadigh, B.A. Glenn, D. Hamilton, R. Bastani, W. Hsu, J.W. Goldman, A. Ghasemiesfe, E.K. Tong, H. Leisy, J. Seibles, L. Rios, M. Chen, T. Yarbrough, M. Vella, B. Antonelli, Y. Gesthalter, D.R. Strong, G. Cheng, N. Patel, J. Hudson, D. Moghanaki, D.T. Cooke, A. Prosper
Journal: Journal of Thoracic Oncology (2024)
OA14.06 Divarasib Single-Agent Long-Term Follow-up and Atezolizumab Combination Treatment in Patients with KRAS G12C-Positive NSCLC
Authors: A. Sacher, W.H. Miller, L. Paz-Ares, M.-J. Ahn, M. Patel, R. Dziadziuszko, A. Santoro, J. Luo, B. Markman, P. Freres, M. Van Dongen, J. Desai, S. Bowyer, A. Cervantes, J. Mourão Dias, A. Falcon, M.G. Krebs, S. Laurie, H. Prenen, R. Perets, E. Massarelli, S.H. Kim, M. de Miguel, S. Deva, E. Garralda, L. Medina, J.D. Guedes, S. Siena, T. Guren, E. Fernandez, L. Latten Jansen, R. De Cassia Costamilan, Y. Choi, S. Mandlekar, M.T. Lin, K.K. Yau, J. Chang, S. Royer-Joo, T. Jun, N.V. Dharia, J.L. Schutzman, P. Lorusso
Journal: Journal of Thoracic Oncology (2024)
MA06.05 A Phase II Study of Lorlatinib in Advanced ROS1+ NSCLC Pre-Treated with Crizotinib and Platinum-Based Chemotherapy
Authors: H. Chen, Y.-L. Wu, Z. Huang, L. Sun, X. Li, L. Chen, J. Li, Z. Zhu, W. Zhuang, K. Lu, Y. Zhang, K. Wang, Y. Chen, D. Huang, J. Zhao, Y. He, P. Zhang, X. Meng, Y. Du, Y. Guo, X. Dong, A. Liu, J. Li, S. Cang, Q. Wang, T. Fang, H. Dai, S. Yao, Q. Shi, J. Yang
Journal: Journal of Thoracic Oncology (2024)
OA03.04 Predicting Disease Progression to Upfront Pembrolizumab Monotherapy in Advanced NSCLC with Machine Learning and CT Radiomics
Authors: I. Janzen, Q. Ye, J. Li, C. Ho, B. Melosky, S. Lam, C. MacAulay, R. Yuan
Journal: Journal of Thoracic Oncology (2024)
MA04.03 Bringing Equity to the Community: The Dana-Farber Cancer Care Equity Program's Lung Cancer Screening Initiative
Authors: N. Florez, S. Pohl, Z. Wei, L. Kiel, T. Patwary, E. Mazzola, L. Garber, E. Harding, L. Svoboda, C. Lathan
Journal: Journal of Thoracic Oncology (2024)
MA05.10 Presenting Features and Diagnostic Delays of NUT Carcinoma: A Report from the NUT Carcinoma Registry
Authors: J. Luo, S.A. Walton, J.J. Kim, F. Paoloni, J.W. Liew, Z.Z. Cotzany, T. Nguyen, P.K. Paik, J.E. Chaft, R. Hsu, S.A. Piha-Paul, P.A. Jänne, D.A. Barbie, L.M. Sholl, S.G. DuBois, G.J. Hanna, G.I. Shapiro, C.A. French
Journal: Journal of Thoracic Oncology (2024)
OA15.04 Multi-Omic Profiling of Paired Non-Small Cell Lung Cancer and Draining Lymph Nodes Reveals Novel T-Cell Differentiation Patterns
Authors: V. Gerretsen, W. de Koning, X. Li, N. Rozendaal, R. Stadhouders, M. Schuijs, B. Lambrecht, J. Aerts, F. Dammeijer
Journal: Journal of Thoracic Oncology (2024)
MA02.11 Validation of the Sybil Deep Learning Lung Cancer Risk Prediction Model in Three Independent Screening Studies
Authors: R. Phellan Aro, S. Lam, M.T. Warkentin, G. Liu, B. Diergaarde, J.-M. Yuan, D.O. Wilson, R. Meza, R. Myers, R.J. Hung
Journal: Journal of Thoracic Oncology (2024)
MA06.03 Efficacy and Safety of Taletrectinib in Patients with ROS1+ Non-Small Cell Lung Cancer: The Global TRUST-II Study
Authors: G. Liu, N. Yang, C.-M. Choi, Y. Ohe, S. Sugawara, N. Yanagitani, F. De Braud, J. Nieva, M. Nagasaka, C. Zhou, E. Felip, X. Zhang, R.K. Lai, S. Li, N.A. Pennell, M. Pérol, L. Bazhenova
Journal: Journal of Thoracic Oncology (2024)
MA01.03 Neoadjuvant Alectinib in Potentially Resectable Stage III ALK-Positive NSCLC: Interim Analysis of ALNEO-GOIRC-01-2020 Phase II Trial
Authors: A. Leonetti, L. Boni, L. Gnetti, D.L. Cortinovis, F. Mazzoni, G. Pasello, F. Passiglia, A. Bearz, S. Pilotto, F. Gelsomino, G. Metro, F. Bertolini, L. Toschi, H. Soto Parra, A. Delmonte, F.L. Cecere, S. Ricciardi, E. Bria, M. Tognetto, M. Tiseo
Journal: Journal of Thoracic Oncology (2024)
OA11.05 Results of a Phase III Trial of Prolgolimab with Chemotherapy as First-Line Therapy for Patients with Advanced Non-Squamous NSCLC: DOMAJOR
Authors: K. Laktionov, A. Smolin, D. Stroyakovsky, V. Moiseenko, M. Dvorkin, T. Andabekov, Y. Cheng, B. Liu, V. Kozlov, S. Odintsova, S. Dvoretsky, A. Mochalova, M. Urda, T. Yi, X. Li, U. László, V. Müller, K. Bogos, N. Fadeeva, G. Musaev, Q. Liu, D. Kirtbaya, J. Shi, O. Gladkov, M. Narimanov, T. Semiglazova, A. Khasanova, J. Chovanec, I. Andrašina, A. Szabová, O. Rosinská, D. Sudekova, P.-S. Zsolt, F. Ran, M. Sun, O. Jiang, R. Chen, E. Zhao, C. Liu, W. Tan, A. Pirmagomedov, E. Poddubskaya, N. Kislov, I. Shumskaya, A. Zinkina-Orikhan, Y. Linkova, D. Liaptseva, A. Siljutina, I. Sorokina, F. Kriukov
Journal: Journal of Thoracic Oncology (2024)
OA10.05 Phase I Trial of DLL3/CD3 IgG-Like T-Cell Engager BI 764532 in Patients with DLL3-Positive Tumors: Patients with LCNEC
Authors: M. Wermke, V. Gambardella, Y. Kuboki, O.B. Alese, D. Morgensztern, C. Sayehli, M.F. Sanmamed, E. Arriola, J. Wolf, L. Villaruz, M. Studeny, M. Bouzaggou, X. Fang, E. Felip
Journal: Journal of Thoracic Oncology (2024)
MA03.10 Association of Surgical Margin Distance, Locoregional Recurrence, and Survival Among Patients Undergoing Sublobar Resection in CALGB140503
Authors: L.W. Martin, C.-F. Yang, X. Wang, B. Damman, T.E. Stinchcombe, J. Mentlick, R. Landreneau, D. Wigle, D.R. Jones, M. Conti, A.S. Ashrafi, M. Liberman, M. de Perrot, J.D. Mitchell, R. Keenan, T. Bauer, D. Miller, N. Altorki
Journal: Journal of Thoracic Oncology (2024)
MA01.05 Efficacy and Safety of Neoadjuvant Camrelizumab and Apatinib Combined with Chemotherapy in Stage IIIA (N2) NSCLC: A Single Arm, Phase II Trial
Authors: L. Zhao, W. Chen, T. Guo, Y. Huang, L. Zhu, S. Chen, X. Chen, Y. Zhang, Y. Yang, X. Pan
Journal: Journal of Thoracic Oncology (2024)
MA01.12 Survival Outcomes and Pathologic Response after Chemo-Immunotherapy in Resectable NSCLC: An Individual Patient Data Meta-Analysis
Authors: D. Marinelli, A. Nuccio, A. Di Federico, F. Ambrosi, P. Bertoglio, E. Faccioli, R. Ferrara, A. Ferro, R. Giusti, F. Guerrera, M. Mammana, A. Pittaro, M. Sepulcri, G. Viscardi, F.T. Gallina
Journal: Journal of Thoracic Oncology (2024)
MA02.05 Inter-Reader Agreement of AI Versus Human Readers in Baseline LDCT Lung Nodule Classification; A UKLS Trial Dataset Sub-Study
Authors: H.L. Lancaster, B. Jiang, J.W.C. Gratama, M. Silva, G.H. de Bock, J.K. Field, M.A. Heuvelmans, M. Oudkerk
Journal: Journal of Thoracic Oncology (2024)
OA17.06 Impact of Using Smoking Duration in Place of Pack-Years as Eligibility Criteria for Lung Cancer Screening to Reduce Racial and Ethnic Disparities
Authors: C.C. Su, V.Y. Ding, K.t. Haaf, J.T. Wu, N.D. Freedman, L.M. Backhus, A.N. Leung, N.S. Lui, C.A. Haiman, S.-S.L. Park, J.W. Neal, R. Meza, M.C. Tammemägi, I. Cheng, L.L. Marchand, H.A. Wakelee, E. Choi, S.S. Han
Journal: Journal of Thoracic Oncology (2024)
MA01.07 Long-Term Analysis of NRG-LU001, Randomized Phase II Trial of Concurrent Chemoradiotherapy (ccrt) -/+ Metformin in Locally Advanced NSCLC.
Authors: T. Tsakiridis, C. Hu, H. Skinner, R. Santana-Davila, B. Lu, J.J. Erasmus, A.J. Doemer, G.M. Videtic, F. Wang, M. Hesselle, R.Y. Lee, M. Werner-Wasik, P.E. Schaner, S.E. McCormack, B.T. Esparaz, R.C. McGarry, J. Brownstein, T. Struve, J.A. Lyness, J.D. Bradley
Journal: Journal of Thoracic Oncology (2024)
MA06.04 Unecritinib in Patients with ROS1 Positive Advanced Non-Small Cell Lung Cancer: Updated Results from a Phase II Trial
Authors: S. Lu, H. Pan, L. Wu, Y. Yao, J. He, Y. Wang, X. Wang, Y. Fang, Z. Zhou, X. Wang, X. Cai, Y. Yu, Z. Ma, X. Min, Z. Yang, L. Cao, H. Yang, Y. Shu, W. Zhuang, S. Cang, J. Fang, K. Li, Z. Yu, J. Cui, Y. Zhang, M. Li, X. Wen, J. Zhang, W. Li, J. Shi, X. Xu, D. Zhong, Z. Li
Journal: Journal of Thoracic Oncology (2024)
MA01.13 Adherence to Treatment Protocol of Patients Submitted to Neoadjuvant (Chemo) Immunotherapy in Resectable NSCLC: Ameta Analysis
Authors: F. Guerrera, F.T. Gallina, E. Balzani, D. Marinelli, A. Nuccio, R. Ferrara, A. Di Federico, F. Ambrosi, E. Faccioli, M. Mammana, A. Ferro, M. Sepulcri, R. Giusti, A. Pittaro, G. Viscardi, P. Bertoglio
Journal: Journal of Thoracic Oncology (2024)
MA02.04 High Detection Rate of Blood MicroRNA Test in Lung Cancer Screening Eligible Individuals.
Authors: G. Sozzi, F. Sabia, L. Rolli, M. Segale, P. Suatoni, A. Zanghi', M. Ruggirello, A. Marchiano', M. Boeri, U. Pastorino
Journal: Journal of Thoracic Oncology (2024)
OA12.05 APOLO: Phase II Trial of Induction Chemo-Immunotherapy Plus Chemoradiotherapy and Maintenance Immunotherapy in Stage III NSCLC
Authors: M. Provencio, B. Campos, M. Guirado, L. Vilà, M.R. García Campelo, M. Dorta, S. Vázquez Estévez, A. Ferrández, M.A. Sala, A.L. Ortega, A. Blasco, A. Insa, M.C. Areses, I. Sullivan, R. López Castro, V. Calvo, D. Rodríguez - Abreu, J. Bosch-Barrera, A. López-Martín, R. Marsé, L. Torrado, K. Matskov, J. Giner, M. Fernández Bruno, E. Sánchez Saugar, C. Martínez-Toledo, A. Cruz-Bermudez
Journal: Journal of Thoracic Oncology (2024)
OA10.04 Tarlatamab with a PD-L1 Inhibitor as First-Line Maintenance after Chemo-immunotherapy for ES-SCLC: DeLLphi-303 Phase 1b Study
Authors: S. Lau, M.-J. Ahn, M. Moskovitz, M. Pogorzelski, S. Haefliger, K.G. Paulson, A. Parkes, Y. Zhang, A. Hamidi, M. Wermke
Journal: Journal of Thoracic Oncology (2024)
OA07.05 Phase 3 Study of HR20013 For Prevention of Cisplatin-based Chemotherapy-induced Nausea and Vomiting (PROFIT Study)
Authors: L. Zhang, Y. Zhao, M. Zhang, J. Yao, S. Leng, X. Li, L. Lin, J. Chen, S. Zhang, X. Qin, Z. Qin, T. Yi, R. Wang, X. Li, Y. Yu, Z. Wang, Q. Zheng, J. Mei, Y. Wang, H. Wang
Journal: Journal of Thoracic Oncology (2024)
OA11.03 Efficacy and Safety of Rilvegostomig, an Anti-PD-1/TIGIT Bispecific, for CPI-naïve Metastatic NSCLC with PD-L1 1-49% or ≥50%
Authors: T.J.N. Hiltermann, H. Izumi, B.C. Cho, S. Cunha, P. Danchaivijitr, E. Felip, G.F. Ho, K. Leventakos, Y. Li, S. Sugawara, P.J. Voon, E. Wauters, T.-Y. Yang, M. Brandão, H. Chen, I. Achour, S. Colebrook, K. Sone, N. Bhulani, D. Karanovic, Y. Wang
Journal: Journal of Thoracic Oncology (2024)
OA14.03 Garsorasib in KRAS G12C-Mutated Non-Small-Cell Lung Cancer: Updated Results from a Phase 2 Study
Authors: Z. Li, S. Lu, X. Dang, D. Huang, S. Jin, W. Li, J. Shi, X. Wang, Y. Zhang, Z. Song, J. Zhang, W. Zhuang, X. Liu, L. Jiang, X. Meng, M. Zhao, J. Zhou, L. Zhang, P. Wang, H. Luo, J. Yang, S. Cang, X. Wang, J. Wang, J. Cui, Y. Yu, Z. Zhang, J. Lu, W. Yang, G. Li, J. Feng, D. Lv, L. Wu, Y. Fang, Y. Wang, Y. Zhao, B. Cao, W. Zhu, Z. Zhuang, Q. Li, M. Wang, H. Zhou, X. Dong, S. Hu, J. Fang, C.-W. Xu, W. Wang, Z. Xiang, Z. Shi, L. Zhang
Journal: Journal of Thoracic Oncology (2024)
OA08.04 Plinabulin/Docetaxel vs. Docetaxel in 2L/3L NSCLC after Platinum Regimens (DUBLIN-3): A Phase 3 Randomized Controlled Trial
Authors: T. Feinstein, B. Han, Y. Shi, G. Chen, Y. Yao, C. Hu, J. Shi, J. Feng, H. Wu, Y. Chen, Q-s. Guo, Z. Jie, F. Ye, Y. Zhang, Z. Liu, W. Mao, L. Zhang, J. Lu, J. Zhao, L. Bazhenova, J. Ruiz, G. Kloecker, S. Kalmadi, I. Oliff, M. Wong, B. Liu, Y. Wu, L. Huang, Y. Sun, F. Luo, J-y. Zhou, H. Pan, H. Wang, C. Liu, L. Cao, C. Huang, E. Thara, X. Li, D. Jiang, R.B. Mowat, J.S. Hrom, A. Nagrial, V. Jain, N.A. Karim, L.V. Shunyakov, A. Kiberu, R. Jennens, K. Lloyd, Z. Wang, L. Du
Journal: Journal of Thoracic Oncology (2024)
OA07.05 Improving Supportive and Social Care in Lung Cancer with the 4R Oncology Model for Patient Care Planning and Delivery
Authors: M. Pasquinelli, C.B. Weldon, N. Mohindra, L. Feldman, F. Weinberg, R. Nguyen, C. Chan, S. Houseknecht, J. Feliciano, R. Sacks, M.S. Weinfeld, W. Waugh, J. Martin, J. Woodyard, P. Khosla, T. Lycan, N. Martin, A. Ravelo, A. Lile, J.R. Trosman
Journal: Journal of Thoracic Oncology (2024)
OA18.03 Real-World Data on the Efficacy and Safety of Lenvatinib in Patients with Previously Treated Thymic Carcinoma
Authors: N. Mamesaya, K. Takagi, G. Saito, H. Tanaka, S. Kubo, T. Shukuya, R. Tsugitomi, T. Sasaki, T. Oba, T. Yamanaka, M. Tachihara, H. Gyotoku, H. Nagashima, M. Tamiya, H. Kanemura, T. Tozuka, M. Furuta, S. Sakata, A. Mouri, H. Miwa, H. Kawachi, T. Ninomiya, Y. Nagai, H. Ogino, K. Ito, Y. Tamura, T. Tokito, M. Ishihara, T. Suzuki
Journal: Journal of Thoracic Oncology (2024)
OA18.05 Neoadjuvant Versus Adjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial
Authors: Y. Zhu, X. Sun, L. Wu, Q. Chen, Q. Wei, P. Ye, S. Han, X. Yu, J. Liu, Q. Zhao, Y. Jiang, X. Zhou, W. Zhang, W. Mao, Y. Xu
Journal: Journal of Thoracic Oncology (2024)
OA03.05 Deep Muitiple Instance Learning-Enabled Gene Mutation Prediction of Lung Cancer from Histopathology Images
Authors: S. Xiong, Y. Zhao, Q. Ren, M. Li, L. Yang, D. Wu, K. Tang, X. Pan, F. Chen, W. Wang, S. Jin, X. Liu, G. Lin, W. Yao, L. Cai, Y. Yang, J. Liu, J. Wu, W. Fu, K. Sun, F. Li, B. Cheng, S. Zhan, H. Wang, Z. Yu, X. Liu, R. Zhong, H. Wang, P. He, Y. Zheng, P. Liang, L. Chen, T. Hou, B. He, J. Song, L. Wu, C. Hu, J. He, J. Yao, W. Liang
Journal: Journal of Thoracic Oncology (2024)
OA06.04 Phase II Study of Pembrolizumab and Itacitinib for Patients with Metastatic NSCLC Expressing PD-L1: Long-Term Follow up
Authors: M.E. Marmarelis, D.J. Cantor, D. Mathew, T. McWilliams, J. Bauml, W.-T. Hwang, A. Singh, C. D'Avella, C. Davis, D. Ye, L. Sun, C. Ciunci, C. Aggarwal, R.B. Cohen, A. Minn, J. Wherry, C.J. Langer
Journal: Journal of Thoracic Oncology (2024)
OA12.04 Neoadjuvant Concurrent Chemo-Immuno-Radiation Therapy Followed by Surgery for Stage III-N2 NSCLC: SQUAT Trial (WJOG 12119L)
Authors: S. Toyooka, A. Hamada, J. Soh, A. Hata, K. Nakamatsu, M. Shimokawa, Y. Yatabe, J. Suzuki, M. Tsuboi, H. Horinouchi, Y. Sakairi, M. Tanahashi, H. Yamamoto, M. Okada, N. Matsuura, H. Shigematsu, Y. Nishimura, N. Yamamoto, K. Nakagawa, T. Mitsudomi
Journal: Journal of Thoracic Oncology (2024)
MA17.04 Patient-Reported Outcomes (PROs) With Consolidation Durvalumab Versus Placebo Following cCRT in Limited-Stage SCLC: ADRIATIC
Authors: S. Novello, Y. Cheng, D. Spigel, J. Fang, Y. Chen, Y. Zenke, K.H. Lee, A. Navarro, E. Buchmeier, J.W.-C. Chang, I. Okamoto, M. Özgüroğlu, Y.J. Kim, N.T.T. Hoa, S. Hashemi, R. Turner, H. Mann, Y. Olivo, H. Jiang, S. Senan
Journal: Journal of Thoracic Oncology (2024)
MA14.07 Access Disparities to Lung Cancer Radiotherapy Across Brazil: An Observational Analysis
Authors: A.G. Gouveia, D. Del Rosso, G.A. Viani, T. Tsakiridis, M.T. M. Starling, A.A. Rosa, M.S. Castilho, G.N. Marta, C.F. de Sousa, H.A. Carvalho, A.A. Jacinto, E.F. Rauber, F.Y. Moraes
Journal: Journal of Thoracic Oncology (2024)
MA14.03 Breathing Dangers: Unraveling Particulate Matter and Asbestos-Associated Lung Cancer Trends in the Top Ten Most Populous Countries
Authors: C.T. Jani, D. Morgenstern-Kaplan, S. Kareff, G. Hanbury, A.S. Salazar, H. Singh, E. Rodriguez, G. Lopes
Journal: Journal of Thoracic Oncology (2024)
MA14.04 Global Burden and Trends of Asbestos-Related Thoracic Cancers &amp; Their Associations with National Asbestos Ban Status: A Cross-Sectional Study
Authors: W.-Z. Li, H. Liang, W. Wang, J. Liu, S. Lv, X. Gui, W. Liang, J. He
Journal: Journal of Thoracic Oncology (2024)
MA15.12 Aumolertinib as Adjuvant Therapy in Resectable I-III EGFR-Mutant NSCLC : Also Effective in Patients with High-Risk Relapse Factors
Authors: J. Yao, W. Song, R. Wang, S. Gu, Q. Zhang, J.L. Zou, C.H. Zhong, R.C. Qu, L. Chen
Journal: Journal of Thoracic Oncology (2024)
MA17.03 30 Years of International Real World Outcomes in Patients with Limited Disease Small Cell Lung Cancer
Authors: S. Khan, K. Hueniken, C.M. Brown, K. Tan, A.S. Wenzlaff, G. Fernandez-Tardon, A. Pesatori, M.J. Barnett, J. Kothari, H. Ma, M. Pérez-Ríos, M.P.A. Davies, B. Schöttker, J. Xie, N.B. Leighl, M. Tsao, J. Zhang, H. Brenner, A.S. Andrew, Y. Wang, J.K. Field, A. Ruano-Ravina, M.B. Schabath, H. Shen, L. Le Marchand, D.C. Christiani, M.L. Neuhouser, M.T. Landi, A. Tardon, F. Taylor, A.G. Schwartz, P. Yang, R.J. Hung, W. Xu, F.A. Shepherd, G. Liu
Journal: Journal of Thoracic Oncology (2024)
MA14.08 Revolutionizing Survival: The Real-World Impact of High-Cost Therapies on Advanced NSCLC
Authors: R. RUIZ, K. ROQUE, M. GALVEZ-NINO, H. VALLEJOS, J.M. ARAUJO, M. OLIVERA HURTADO DE MENDOZA, N. VALDIVIEZO, O. COANQUI, M.W. CASTRO-MOLLO, M. CALDERON, L. MAS
Journal: Journal of Thoracic Oncology (2024)
MA14.11 Duration of Intervals in the Care-Seeking Pathway of Lung Cancer in Nepal - Unraveling the Delays from Symptom Onset to Treatment Initiation
Authors: S. Pandey, B.D. Paudel, B. Acharya, S.C. Acharya, A. Karn, S. Poudyal, P. Thapa, J. Gurung, R. Shilpakar
Journal: Journal of Thoracic Oncology (2024)
MA15.07 Preliminary Analysis of Adjuvant Chemotherapy with Atezolizumab in Stage I-III Resected NSCLC and Clearance of ctDNA
Authors: R. Maniar, E. Shum, N.A. Mohindra, D.H. Owen, P.C. Ma, M. Haigentz, R.D. Hall, S.A. Rajguru, J. Grindheim, K. Schulze, N.H. Hanna
Journal: Journal of Thoracic Oncology (2024)
MA18.03 Participant Eligibility for Lung Cancer Screening in Australia: An Analysis of Proposed Criteria
Authors: C. Kumarasamy, K. Betts, R. Norman, A. McWilliams, E. Stone, D.C.-L. Lam, R. Manser, P. Fogarty, H. Marshall, S. Lam, M.C. Tammemägi, K.M. Fong, S. Atkar-Khattra, F. Brims
Journal: Journal of Thoracic Oncology (2024)
MA12.06 PAPILLON: TP53 Co-mutations, Sites of Insertion, and ctDNA Clearance Among Patients with EGFR Ex20ins-Mutated Advanced NSCLC
Authors: J.W. Goldman, B.C. Cho, S. Cheng, C. Zhou, B. Liu, Y. Yao, A. Alip, Y.J. Kim, H.J. Soto Parra, T. Kawamura, O. Hataji, H. Hayashi, B. Zurawski, U. Batra, V. Santos, E. Teixeira, C. Dooms, J. Alatorre-Alexander, N. Girard, A.I. Spira, C. Kim, J.K. Sabari, S. Popat, K. Park, R.E. Sanborn, J.C. Curtin, J. Zhang, X. Luo, X. Lyu, A. Bhattacharya, P. Lorenzini, H. Wortman-Vayn, M. Baig, T. Agrawal, R.E. Knoblauch, A.S. Mansfield
Journal: Journal of Thoracic Oncology (2024)
MA15.05 Follow-Up Update of Molecular Residual Disease in Localized Non-Small Cell Lung Cancer
Authors: J.-T. Zhang, X. Gao, S.-Y. Liu, Z. Jiao, S. Dong, Y. Pan, Q. Zhou, W.-Z. Zhong, X.-N. Yang, X. Yi, Y.-L. Wu
Journal: Journal of Thoracic Oncology (2024)
MA14.13 Analysis of Lung Cancer-Specific Patient-Reported Outcome Measures (PROMs): Results from the PRO4All Project
Authors: A. Servetto, F. Malandrini, M. Meregaglia, A.A. Valsecchi, C. Bennati, F. Giovanardi, C. Pinto, M. Di Maio, O. Ciani
Journal: Journal of Thoracic Oncology (2024)
MA09.04 Differential CD8+FoxP3+ T Cell Infiltration Patterns Associate with Pathologic Response after Neoadjuvant Anti-PD-1 in NSCLC
Authors: M. Fotheringham, B. Green, J.S. Roskes, E. Cohen, B. Zhang, L.L. Engle, D. Wang, D. Jimenez-Sanchez, J.X. Caushi, J. Zhang, N. D'Amiano, J.C. Sunshine, J.S. Deutsch, S. Uttam, A. Fiorante, N.A. Espinosa, T. Popa, A. Ogurtsova, S. Soto-Diaz, M. Eminizer, D. Medvedev, J.E. Chaft, J.R. Brahmer, M. Conroy, J. Reuss, H. Ji, P.M. Forde, D.M. Pardoll, K.N. Smith, A.S. Szalay, J.M. Taube, T.R. Cottrell
Journal: Journal of Thoracic Oncology (2024)
MA12.08 Preventing Infusion-Related Reactions with Intravenous Amivantamab: Primary Results from SKIPPirr, a Phase 2 Study
Authors: G. Lopes, A.I. Spira, J.-Y. Han, J.-Y. Shih, C. Mascaux, U. Basu Roy, J. Zugazagoitia, Y.J. Kim, C.-H. Chiu, S.-W. Kim, E. Nadal, I. Gil-Bazo, S. Murphy, P. Mahadevia, B.G. Anderson, K. Xia, G. Wang, J.M. Bauml, M. Chioda, J. Simoes, L. Paz-Ares
Journal: Journal of Thoracic Oncology (2024)